Knockdown of CD146 reduces the migration and proliferation of human endothelial cells

Yanyong Kang1, Fengcai Wang, Jing Feng

  • 1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Science, Beijing 100101, China.

Cell Research
|March 17, 2006
PubMed

Insights

CD146 molecule is crucial for blood vessel formation and tumor growth. Blocking CD146 with siRNA significantly suppressed endothelial cell activity, indicating its potential as an anti-angiogenesis therapy target.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • CD146 molecule identified as a biomarker on vascular endothelium.
  • CD146's involvement in angiogenesis and tumor growth previously suggested.
  • The precise mechanism of CD146's function remained unclear.

Purpose of the Study:

  • To investigate the functional role of CD146 in endothelial cells.
  • To develop a novel CD146 blockade system using siRNA.
  • To assess the impact of CD146 inhibition on endothelial cell activity and angiogenesis.

Main Methods:

  • Development of a CD146 siRNA system for targeted gene silencing.
  • Assessment of CD146 expression at both mRNA and protein levels.
  • Evaluation of human umbilical vein endothelial cell (HUVEC) proliferation, adhesion, and migration.

Main Results:

  • CD146 siRNA effectively and specifically blocked CD146 expression.
  • Significant suppression of HUVEC proliferation observed.
  • Inhibition of HUVEC adhesion and migration demonstrated.

Conclusions:

  • CD146 plays a critical role in vascular endothelial cell function and angiogenesis.
  • CD146 siRNA effectively inhibits endothelial cell activity.
  • CD146 siRNA presents a potential therapeutic strategy for anti-angiogenesis therapy.